BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31183445)

  • 1. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
    DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
    BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients.
    Craig SJ; Bysice AM; Nakoneshny SC; Pasieka JL; Chandarana SP
    Thyroid; 2020 Feb; 30(2):222-228. PubMed ID: 31813323
    [No Abstract]   [Full Text] [Related]  

  • 3. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Wrenn SM; Wang TS; Toumi A; Kiernan CM; Solórzano CC; Stephen AE
    Am J Surg; 2021 Feb; 221(2):448-454. PubMed ID: 32933747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
    Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
    J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
    Vargas-Pinto S; Romero Arenas MA
    J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
    James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
    Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features.
    Xu S; Huang H; Wang X; Liu S; Xu Z; Liu J
    Br J Surg; 2021 Apr; 108(4):395-402. PubMed ID: 33793787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.
    Kluijfhout WP; Pasternak JD; Lim J; Kwon JS; Vriens MR; Clark OH; Shen WT; Gosnell JE; Suh I; Duh QY
    Thyroid; 2016 Jun; 26(6):820-4. PubMed ID: 27083216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of functional outcomes after total thyroidectomy and completion thyroidectomy: Hypoparathyroidism and postoperative complications.
    Park YM; Kim JR; Oh KH; Cho JG; Baek SK; Kwon SY; Jung KY; Woo JS
    Auris Nasus Larynx; 2019 Feb; 46(1):101-105. PubMed ID: 29636205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable Early Outcomes With Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: The Mayo Clinic Experience.
    Merten MM; Foster T; Lyden M; Henry M; Regina Castro M
    Am Surg; 2021 Sep; 87(9):1374-1378. PubMed ID: 34468234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial Thyroidectomy for Papillary Thyroid Microcarcinoma: Is Completion Total Thyroidectomy Indicated?
    Donatini G; Castagnet M; Desurmont T; Rudolph N; Othman D; Kraimps JL
    World J Surg; 2016 Mar; 40(3):510-5. PubMed ID: 26546190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
    Ahn D; Lee GJ; Sohn JH
    Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative hypoparathyroidism after total thyroidectomy for thyroid cancer.
    Teshima M; Otsuki N; Morita N; Furukawa T; Shinomiya H; Shinomiya H; Nibu KI
    Auris Nasus Larynx; 2018 Dec; 45(6):1233-1238. PubMed ID: 29747960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.
    Ritter A; Bachar G; Hirsch D; Benbassat C; Katz O; Kochen N; Diker-Cohen T; Akirov A; Shimon I; Robenshtok E
    J Clin Endocrinol Metab; 2018 Feb; 103(2):407-414. PubMed ID: 29240898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.
    Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Song DE; Sung TY; Yoon JH; Hong SJ; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2017 Apr; 176(4):371-378. PubMed ID: 28089996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversy: For or against thyroid lobectomy in>1cm differentiated thyroid cancer?
    Menegaux F; Lifante JC
    Ann Endocrinol (Paris); 2021 Apr; 82(2):78-82. PubMed ID: 33757822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent of surgery for low-risk 1-4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35.
    Anda Apiñániz E; Zafon C; Ruiz Rey I; Perdomo C; Pineda J; Alcalde J; García Goñi M; Galofré JC
    Endocrine; 2020 Dec; 70(3):538-543. PubMed ID: 32507966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.